Showing 311-320 of 10531 results for "".
To Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.CSF 2017 Sneak Peek: Joel on Joel
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/csf-2017-sneak-peek-joel-on-joel/18402/Learn about the philosophy of Cosmetic Surgery Forum and get a taste for what the 2017 meeting will offer in this conversation between Joel L. Cohen, MD and CSF Founder, Joel Schlessinger, MD. Cosmetic Surgery Forum will be held November 29 thru December 2 at the Ballagio, Las Vegas.Science of Skincare Summit 2024:What's Going On With Medical Dermatology?
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-whats-going-on-with-medical-dermatology/29451/Todd Schlesinger, MD, James Del Rosso, DO, and Neal Bhatia, MD, discuss challenges facing medical dermatology, and what can be done to save it, as well as the importance of encouraging young dermatologists to become involved with clinical research. This discussion was recorded at the Science of SkinScience of Skincare Summit 2024: Ethical Relationships with Industry
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-ethical-relationships-with-industry/29455/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Nada Elbuluk, MD, a dermatologist at the University of Southern California specializing in pigmentary disorders and skin of color, about building relationships with industry that maintain proper independence and compliance with pScience of Skincare Summit 2024:Presentation of Disease in Patients with Skin of Color
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-presentation-of-disease-in-patients-with-skin-of-color/29456/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Nada Elbuluk, MD, a dermatologist at the University of Southern California specializing in pigmentary disorders and skin of color, about some of the challenges of diagnosing disease such as erythema in patients with skin of colorFactor in Patient Satisfaction Matrix for Best Results
https://practicaldermatology.com/conferences/maui-derm-2024/factor-in-patient-satisfaction-matrix-for-best-results/20249/Chief Medical Editor Neil Bhatia, MD speaks with Maui Derm presenter and educator William P. Werschler, MD about cosmetic updates, including his “patient satisfaction matrix” that helps doctors and patients align on expectations of the outcomes of procedures.Beyond SPF: Protecting the Skin
https://practicaldermatology.com/topics/skin-cancer-photoprotection/beyond-spf-protecting-the-skin-/18535/In addition to protecting the skin from sun damage, it's becoming increasingly important to consider pollution's role in skin aging. Arianne Shadi Kourosh, MD, and Rebecca Kazin, MD discuss the need for a well tailored regimen and what to look for in sun protection, barrier protection, cleaners, anMechanisms of Action for IL-17 Inhibition in Treating Psoriasis and Hidradenitis Suppurativa
https://practicaldermatology.com/programs/practical-dermatology-il-17-journal-club/mechanisms-of-action-for-il-17-inhibition-in-treating-psoriasis-and-hidradenitis-suppurativa/48808/Practical Dermatology Editorial Board member Jason E. Hawkes, MD, MS, FAAD, joins Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss articles from the Journal of Clinical Medicine and Clinics in Dermatology on how IL-17 inhibition is effective in treating psoriasis and hidradenitis suppurativa,Lidocaine Shortage Update
https://practicaldermatology.com/conferences/scale-2023/lidocaine-shortage-update/20196/The current lidocaine and lidocaine with epinephrine shortage is affecting practices across the country. Joel L. Cohen, MD, and George Hruza, MD, weigh in on the shortage and potential solutions and how to minimize toxicity risks when mixing and matching different anesthetics.Why Assessing Vitiligo Activity is Critical for Limiting Spread
https://practicaldermatology.com/conferences/maui-derm-2024/why-assessing-vitiligo-activity-is-critical-for-limiting-spread/20248/Chief Medical Editor Neal Bhatia, MD talks with “Mr. Vitiligo Himself,” John E. Harris, MD, PhD about the importance of determining whether vitiligo patients are active or stable in order to “shut off” spreading as soon as possible.